These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23289548)

  • 1. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial.
    Matsuoka Y; Nishi D; Yonemoto N; Hamazaki K; Matsumura K; Noguchi H; Hashimoto K; Hamazaki T
    BMC Psychiatry; 2013 Jan; 13():8. PubMed ID: 23289548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial.
    Matsuoka Y; Nishi D; Hamazaki K; Yonemoto N; Matsumura K; Noguchi H; Hashimoto K; Hamazaki T
    J Clin Psychiatry; 2015 Aug; 76(8):e1015-22. PubMed ID: 26335087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of omega-3 polyunsaturated fatty acids on psychophysiological symptoms of post-traumatic stress disorder in accident survivors: A randomized, double-blind, placebo-controlled trial.
    Matsumura K; Noguchi H; Nishi D; Hamazaki K; Hamazaki T; Matsuoka YJ
    J Affect Disord; 2017 Dec; 224():27-31. PubMed ID: 27287561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: a randomized controlled trial.
    Matsuoka Y; Nishi D; Tanima Y; Itakura M; Kojima M; Hamazaki K; Noguchi H; Hamazaki T
    Transl Psychiatry; 2015 Jul; 5(7):e596. PubMed ID: 26151924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-3 supplementation from pregnancy to postpartum to prevent depressive symptoms: a randomized placebo-controlled trial.
    Vaz JDS; Farias DR; Adegboye ARA; Nardi AE; Kac G
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):180. PubMed ID: 28599630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuating posttraumatic distress with omega-3 polyunsaturated fatty acids among disaster medical assistance team members after the Great East Japan Earthquake: the APOP randomized controlled trial.
    Matsuoka Y; Nishi D; Nakaya N; Sone T; Hamazaki K; Hamazaki T; Koido Y
    BMC Psychiatry; 2011 Aug; 11():132. PubMed ID: 21846343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mothers, Omega-3 and mental health study.
    Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
    BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synchronized trial on expectant mothers with depressive symptoms by omega-3 PUFAs (SYNCHRO): Study protocol for a randomized controlled trial.
    Nishi D; Su KP; Usuda K; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Sano Y; Tachibana Y; Ito H; Isaka K; Hashimoto K; Hamazaki T; Matsuoka YJ
    BMC Psychiatry; 2016 Sep; 16(1):321. PubMed ID: 27630014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
    Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
    Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials.
    Kwak SM; Myung SK; Lee YJ; Seo HG;
    Arch Intern Med; 2012 May; 172(9):686-94. PubMed ID: 22493407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential role of brain-derived neurotrophic factor in omega-3 Fatty Acid supplementation to prevent posttraumatic distress after accidental injury: an open-label pilot study.
    Matsuoka Y; Nishi D; Yonemoto N; Hamazaki K; Hamazaki T; Hashimoto K
    Psychother Psychosom; 2011; 80(5):310-2. PubMed ID: 21720194
    [No Abstract]   [Full Text] [Related]  

  • 12. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial.
    Andrieu S; Guyonnet S; Coley N; Cantet C; Bonnefoy M; Bordes S; Bories L; Cufi MN; Dantoine T; Dartigues JF; Desclaux F; Gabelle A; Gasnier Y; Pesce A; Sudres K; Touchon J; Robert P; Rouaud O; Legrand P; Payoux P; Caubere JP; Weiner M; Carrié I; Ousset PJ; Vellas B;
    Lancet Neurol; 2017 May; 16(5):377-389. PubMed ID: 28359749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids in first-episode schizophrenia - a randomized controlled study of efficacy and relapse prevention (OFFER): rationale, design, and methods.
    Pawełczyk T; Grancow M; Kotlicka-Antczak M; Trafalska E; Gębski P; Szemraj J; Żurner N; Pawełczyk A
    BMC Psychiatry; 2015 May; 15():97. PubMed ID: 25934131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
    Lespérance F; Frasure-Smith N; St-André E; Turecki G; Lespérance P; Wisniewski SR
    J Clin Psychiatry; 2011 Aug; 72(8):1054-62. PubMed ID: 20584525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations between increases in plasma n-3 polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers.
    Buydens-Branchey L; Branchey M; Hibbeln JR
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):568-75. PubMed ID: 18060675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study: the updated final trial protocol and rationale of post-initiation trial modifications.
    Viecelli AK; Pascoe E; Polkinghorne KR; Hawley C; Paul-Brent PA; Badve SV; Cass A; Heritier S; Kerr PG; Mori TA; Robertson A; Seong HL; Irish AB;
    BMC Nephrol; 2015 Jun; 16():89. PubMed ID: 26116581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between Japan and Taiwan in the treatment of pregnant women with depressive symptoms by omega-3 fatty acids: An open-label pilot study.
    Nishi D; Su KP; Usuda K; Chang JP; Chiang YJ; Guu TW; Hamazaki K; Nakaya N; Sone T; Hashimoto K; Hamazaki T; Matsuoka YJ
    Nutr Neurosci; 2019 Jan; 22(1):63-71. PubMed ID: 28752805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.
    Grosso G; Pajak A; Marventano S; Castellano S; Galvano F; Bucolo C; Drago F; Caraci F
    PLoS One; 2014; 9(5):e96905. PubMed ID: 24805797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPA but not DHA appears to be responsible for the efficacy of omega-3 long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta-analysis of randomized controlled trials.
    Martins JG
    J Am Coll Nutr; 2009 Oct; 28(5):525-42. PubMed ID: 20439549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.